secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2023-09-14T23:59:59+00:00
Accession:  0001193125-23-235413
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb subsidiary prices $1.4B 8.375% senior secured notes due 2028
--------------------------------------------------------------------------

- Bausch + Lomb subsidiary Bausch + Lomb Escrow Corp. priced $1.4B of 8.375% senior secured notes due 2028.
- Notes priced at 100% of principal; exempt from registration under Securities Act and Canadian securities laws.
- Proceeds expected to fund pending acquisition of XIIDRA and other ophthalmology assets.
- Offering is part of Bausch + Lomb's financing for the acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/0001193125-23-235413-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000119312523235413/d507768d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-235413

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer